Jefferies Group’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,428
Closed -$335K 1236
2022
Q1
$335K Buy
+12,428
New +$335K ﹤0.01% 714